University of Veterinary Medicine Vienna - Research portal

Diagrammed Link to Homepage University of Veterinary Medicine, Vienna

Orlova Anna,

** = Publications listed in SCI/SSCI/Pubmed

2019

Journal Article

** de Araujo, ED; Erdogan, F; Neubauer, HA; Meneksedag-Erol, D; Manaswiyoungkul, P; Eram, MS; Seo, HS; Qadree, AK; Israelian, J; Orlova, A; Suske, T; Pham, HTT; Boersma, A; Tangermann, S; Kenner, L [and 9 others] (2019): Structural and functional consequences of the STAT5B Nat Commun. 2019; 10(1):2517
Open Access Logo

** de Araujo, ED; Orlova, A; Neubauer, HA; Bajusz, D; Seo, HS; Dhe-Paganon, S; Keserű, GM; Moriggl, R; Gunning, PT (2019): Structural Implications of STAT3 and STAT5 SH2 Domain Mutations. Cancers (Basel). 2019; 11(11):1757
Open Access Logo

** Kleinegger, F; Hofer, E; Wodlej, C; Golob-Schwarzl, N; Birkl-Toeglhofer, AM; Stallinger, A; Petzold, J; Orlova, A; Krassnig, S; Reihs, R; Niedrist, T; Mangge, H; Park, YN; Thalhammer, M; Aigelsreiter, A [and 7 others] (2019): Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival. Biochim Biophys Acta Mol Basis Dis. 2019; 1865(2):308-321
Open Access Logo

** Kosack, L; Wingelhofer, B; Popa, A; Orlova, A; Agerer, B; Vilagos, B; Majek, P; Parapatics, K; Lercher, A; Ringler, A; Klughammer, J; Smyth, M; Khamina, K; Baazim, H; de Araujo, ED [and 13 others] (2019): The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease. Cancer Cell. 2019; 35(1):125-139.e9
Open Access Logo

** Lercher, A; Bhattacharya, A; Popa, AM; Caldera, M; Schlapansky, MF; Baazim, H; Agerer, B; Gürtl, B; Kosack, L; Májek, P; Brunner, JS; Vitko, D; Pinter, T; Genger, JW; Orlova, A [and 13 others] (2019): Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function. Immunity. 2019; 51(6):1074-1087.e9
Open Access Logo

** Orlova, A; Neubauer, HA; Moriggl, R (2019): The stromal microenvironment provides an escape route from FLT3 inhibitors through the GAS6-AXL-STAT5 axis. Haematologica. 2019; 104(10):1907-1909
Open Access Logo

** Orlova, A; Wagner, C; de Araujo, ED; Bajusz, D; Neubauer, HA; Herling, M; Gunning, PT; Keserű, GM; Moriggl, R (2019): Direct Targeting Options for STAT3 and STAT5 in Cancer. Cancers (Basel). 2019; 11(12):1930
Open Access Logo

** Rauth, M; Freund, P; Orlova, A; Grünert, S; Tasic, N; Han, X; Ruan, HB; Neubauer, HA; Moriggl, R (2019): Cell Metabolism Control Through O-GlcNAcylation of STAT5: A Full or Empty Fuel Tank Makes a Big Difference for Cancer Cell Growth and Survival. Int J Mol Sci. 2019; 20(5): 1028.
Open Access Logo

2018

** Orlova, A; Wingelhofer, B; Neubauer, HA; Maurer, B; Berger-Becvar, A; Keserű, GM; Gunning, PT; Valent, P; Moriggl, R (2018): Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas. Expert Opin Ther Targets. 2018; 22(1):45-57
Open Access Logo

** Wingelhofer, B; Maurer, B; Heyes, EC; Cumaraswamy, AA; Berger-Becvar, A; de Araujo, ED; Orlova, A; Freund, P; Ruge, F; Park, J; Tin, G; Ahmar, S; Lardeau, CH; Sadovnik, I; Bajusz, D [and 6 others] (2018): Pharmacologic inhibition of STAT5 in acute myeloid leukemia. Leukemia. 2018; 32(5):1135-1146
Open Access Logo

© University of Veterinary Medicine ViennaHelp and Downloads